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Little information is available about the effects of inspiratory muscle training in patients with cystic fibrosis (CF).
In this study the effects of inspiratory-threshold loading in patients with CF on strength and endurance of the
inspiratory muscles, pulmonary function, exercise capacity, dyspnoea and fatigue were evaluated.
Sixteen patients were assigned to one of two groups using the minimization method: eight patients in the training
group and eight patients in the control group.The training was performed using an inspiratory-threshold loading
device. Patients were instructed to use the threshold trainer 20min a day, 5 days a week for 6 weeks. Patients in the
training group trained at inspiratory threshold loads up to 40% of maximal static inspiratory pressure (Pimax) and
patients in the control group got ‘sham’ training at a load of 10% of Pimax. No significant differences were found
among the two groups in gender, age, weight, height, pulmonary function, exercise capacity, inspiratory-muscle
strength and inspiratory-muscle endurance before starting the training programme. Mean (SD) age in the control
group was 19 (5?5) years, mean (SD) age in the training group was 17 (5?2) years. Mean FEV1 in both groups was
70% predicted, mean inspiratory-muscle strength in both groups was above 100% predicted.
All patients except one, assigned to the training group, completed the programme. After 6 weeks of training,
mean inspiratory-muscle endurance (% Pimax) in the control group increased from 50% to 54% (P=0?197); in the
training group mean inspiratory muscle endurance (% Pimax) increased from 49% to 66% (P=0?003). Statistical
analysis showed that the change in inspiratory-muscle endurance (% Pimax) in the training group was significantly
higher than in the control group (P=0?012). After training, in the training group there was a tendency of
improvement in Pimax with an increase from 105 to 123% predicted, which just fell short of statistical significance
(P=0?064). After training no significant differences were found in changes from baseline in pulmonary function,
exercise capacity, dyspnoea and fatigue. It is concluded that low-intensity inspiratory-threshold loading at 40% of
Pimax was sucient to elicit an increased inspiratory-muscle endurance in patients with CF.
Key words: cytic fibrosis; inspiratory muscle training; inspiratory threshold; inspiratory muscle strength; inspiratory
muscle endurance; pulmonary function.
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Cystic fibrosis (CF) is a complex disease which affects
multiple organ systems and thereby physiological functions.
Patients often suffer from impaired pulmonary function,
impaired exercise capacity and poor nutritional status.
Whether dysfunction of inspiratory-muscle strength is
present in CF patients is controversial. A preserved
inspiratory muscle strength has been reported in previous
studies (1,2,3,4), suggesting an inspiratory-muscle training
effect caused by airway obstruction. Lands et al. (5)
suggested that CF patients in a later stage of the diseaseReceived 13 September 1999 and accepted in revised form 11
September 2000.
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Other authors (6,7) also found reduced inspiratory-muscle
strength in CF patients. Lack of eciency of the inspiratory
muscles, as a result of malnutrition (3) and hyperinflation
(6), may lead to development of inspiratory-muscle fatigue
and therefore dyspnoea.
It is thought that specific inspiratory-muscle training may
forestall inspiratory-muscle fatigue and therefore delay
dyspnoea. Most of the previous studies evaluating the
effects of inspiratory-muscle training were performed in
patients with chronic obstructive pulmarary disease
(COPD) and concerned inspiratory-resistive training and
more recently inspiratory-threshold loading.
In CF patients, Keens et al. (8) showed that specific
normocapnic hyperpnoea training improved ventilatory-
muscle endurance. Asher et al. (9) demonstrated increases
in strength and endurance of inspiratory muscles, but no
improvement in exercise capacity after twice daily 15-min
sessions during 4 weeks of inspiratory-muscle training at a# 2001 HARCOURT PUBLISHERS LTD
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(10) compared 10 children with CF who underwent
inspiratory-threshold training at loads up to 60% of
maximal static inspiratory pressure (Pimax) 30 min daily
for 10 weeks with a control group of 10 CF children who
received ‘sham’ training. The experimental group showed
significant improvement in inspiratory-muscle strength,
pulmonary function and exercise capacity.
Apparently, there is a tendency to improve endurance
and strength of the inspiratory-muscles as well as exercise
capacity, after inspiratory-muscle training at high intensity
in CF patients. Whether inspiratory-muscle training at
lower intensity would be beneficial in CF patients has not
been determined yet. Furthermore, less information is
available about the effects of inspiratory-muscle training on
subjective outcome variables. Therefore, the purpose of this
study was to evaluate the effects of inspiratory-threshold
loading at low intensity in patients with CF on strength and
endurance of the inspiratory muscles, pulmonary function,
exercise capacity, dyspnoea and fatigue.
Methods
PATIENTS
Patients with CF (n=16), ranging in age from 10 to 25
years, were recruited on the basis of their willingness to
take part in this study. Clinical characteristics are given in
Table 1. Written informed consent was obtained from the
patients or parents. The study was approved by the Medical
Ethics Committee of the University Hospital.
Patients were assigned to one of two groups by five
patient factors: gender; age; FEV1; FVC; and body mass
index using the minimization method (11). Eight patients inTABLE 1. Characteristics of the patients at baseline (mean SD v
Control group (n=8)
Gender (M/F) 4/4
Age, years 19 (5?5)
Height, cm 169 (13)
Weight, kg 54?6 (12)
FEV1, l 2?46 (1?24)
FEV1, % pred. 70 (29)
FVC, l 3?30 (1?08)
FVC, % pred. 80 (20)
FEV1/IVC, % 67?5 (17?4)
RV, l 1?81 (1?33)
TLC, l 5?21 (1?42)
RV/TLC, % pred. 119 (32)
Wmax, % pred. 72 (20)
IMS, % pred. 129 (32)
IME, % Pimax 50 (5)
IMS: inspiratory muscle strength;
IME: inspiratory muscle endurance; Pimax; maximal static ins
P-value: t-test for unpaired samples.the experimental group trained at inspiratory-threshold
loads up to 40% of Pimax (training group) and eight
patients received ‘sham’ training at a minimal pressure load
of 10% of Pimax (control group).
In both groups, the following variables were measured at
baseline and after 6 weeks of training:
Pulmonary function
Inspiratory vital capacity (IVC), FVC and FEV1 were
measured using body plethysmography (Jaeger, System
2800, Germany). Predicted values of Quanjer et al. were
used to express pulmonary function as a percentage of the
predicted value (12). Residual volume (RV) and total lung
capacity (TLC) were only measured at baseline to
characterize patients. The RV/TLC ratio (% predicted)
was calculated.
Exercise capacity
Exercise capacity was assessed using an automatic electro-
magnetically braked bicycle (Jaeger EOS sprint, Germany)
during continuous ECG recording. Each subject exercised
continuously (pedal speed: 60 rpm) with an initial workload
of 0 Watt for 1min, which was increased every minute by
10 Watts. HR, BF, VE, VO2 and VCO2 were recorded for
5min at baseline and throughout the exercise test. The test
was terminated when exhaustion was apparent or earlier, at
the physician’s discretion, when physiological endpoints
(i.e. decline in blood pressure, ECG changes, attainment of
theoretically maximal heart rate) were exceeded (13). The
maximal workload was defined as the highest load which
could be reached and maintained for at least 0?5min.alues)
Training group (n=8) P-value
4/4
17 (5?2) 0?552
167 (15) 0?724
50 (13) 0?477
2?34 (0?74) 0?823
70 (25) 0?993
3?28 (1?19) 0?984
81 (21) 0?895
68?5 (12?5) 0?905
2?08 (0?99) 0?655
5?44 (1?82) 0?787
137 (32) 0?569
69 (13) 0?768
106 (21) 0?113
48 (12) 0?590
pirator pressure;
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percentage of the predicted maximum exercise capacity
using the equation of Wasserman et al. (14) was used for
analysis. Before exercise and during the last 10 sec of each
work level patients were asked to rate the subjective degree
of dyspnoea using the modified Borg-scale (15). This
category scale is an indicator of the intensity of dyspnoea.
The scale ranges from 0 to 10 where a value of 0 represents
‘nothing at all’ and a value of 10 denotes that the intensity
of dyspnoea is maximal. The Borg-scale was shown to
patients printed on a sheet of paper after a standard set of
instructions (16).
Inspiratory muscles
Strength. Inspiratory-muscle strength was assessed by
measuring Pimax at RV with a portable Pmax Monitor
(P.K. Morgan Ltd., England). The manoeuvre was
repeated until a reproducible pressure plateau was seen.
The highest recorded pressure maintained for 1 sec was
taken for analysis. Values were expressed in cm H2O.
Normal values of Wilson et al. (17) were used to determine
the percentage of predicted values.
Endurance. To determine inspiratory-muscle endurance,
a commercially-available threshold-loading device (Thresh-
old, Healthscan Products, Inc. U.S.A.) was used during an
incremental loading procedure (18,19). In order to obtain
pressures over 41 cm H2O an additional spring was inserted
with a double-spring constant, as described by Gosselink
et al. (20). Patients started inspiring from a threshold-
loading device set at 30% of Pimax for 2min. The threshold
load was then increased every 2min in increments of 10%
of Pimax. The maximal load was defined as the highest load
which could be reached and maintained for at least 1min as
a percentage of Pimax. The breathing pattern was not
regulated. Before assessment and during the last 10 sec of
each load-level, patients were asked to rate the subjective
degree of dyspnoea using the modified Borg-scale.
Training. The training was performed using the thresh-
old-loading device, which has been found to be reliable and
reproducible for loading inspiratory muscles (20).
Patients were instructed to use the threshold trainer
20min a day, 5 days a week, for 6 weeks. Patients of both
groups were asked to continue their normal life-style during
this period, except for completing the prescribed, unsuper-
vised, daily inspiratory-muscle training. Patients in the
training group started to train at a resistance of 20% of
their Pimax, for 1 week. The resistance was then increased
to 30% of Pimax in the second week and to 40% of Pimax
for the last 4 weeks. Patients in the control group breathed
through the threshold trainer with an inspiratory resistance
of 10% of Pimax. This low resistance could be considered
as ‘sham’ training, according to recommendations of Reid
et al. (21) that inspiratory-muscle-training intensity should
be minimally 30% of Pimax to obtain effects.Questionnaires
Patients also completed the following questionnaires at
baseline and at the end of the study:
Subjective fatigue. To determine subjective fatigue the
Fatigue Index 20 (MFI-20) was developed by Smets et al.
(22,23) and used in our study. The psychometric properties
of the MFI-20 have been evaluated in cancer patients,
patients with Chronic Fatigue Syndrome, psychology
students, medical students, army recruits and junior
physicians (22). The MFI-20 has established construct
and convergent validity and shows good internal consis-
tency. The MFI-20 contains 20 positive- and negative-
directed statements that deal with five dimensions of
fatigue, four statements per dimension. Patients are asked
to rate their condition according to the last days. Each
answer consists of an ordinal scale ranging from ‘yes, that’s
correct’ (score 1) to ‘no, that’s incorrect’ (score 5). Scores
range from 1 to 5. A higher score implies more severe
fatigue. A score for each dimension is calculated by
summation of the scores for each question per dimension.
This score can be a minimum of 4 and a maximum of 20.
Likewise a higher score implies more severe subjective
fatigue.
MRC dyspnoea. The Dutch version of the Medical
Research Council (MRC) dyspnoea scale was used to rate
limitation in function due to dyspnoea (24). This scale is
based on six grades with regard to dyspnoea during
physical activities and during rest. To grade dyspnoea with
the MRC scale, patients were interviewed by asking
questions concerning the patient’s symptoms according to
the instructions reported by Van der Lende et al. (25). A
higher MRC grade indicates more impairment due to
dyspnoea.
STATISTICAL ANALYSES
Statistical analyses were performed using the Statistical
Package for the Social Sciences (SPSS-version 7?5). Values
are presented as means (SD).
Differences in recorded variables between the two groups
at baseline were analysed using Student’s t-test for unpaired
samples. The t-test for paired samples was used to compare
pre- and post-training values within each group. For each
individual patient the absolute change from baseline after
the intervention (training or sham) was calculated for all
variables. Differences in change from baseline between the
training and the sham training group were analysed using
the t-test for unpaired samples. A P-value lower than 5%
was considered as statistically significant.
Results
All patients except one, assigned to the training group,
completed the programme. This patient stopped the
programme because of earache during inspiratory-thresh-
old training with a load of 40% of Pimax. Also, this patient
FIG. 1. Mean change in inspiratory muscle endurance (%
Pimax—maximal static inspiratory pressure) in training
group and control group
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programme and was excluded from statistical analysis of
the data of the training period. There were no significant
differences among the two groups in gender, age, weight,
height, pulmonary function, exercise capacity, inspiratory-
muscle strength and inspiratory-muscle endurance before
starting the training programme (Table 1). Mean FEV1 in
both groups was 70% predicted. Mean inspiratory-muscle
strength in the control as well as in the training group was
above 100% predicted. Mean inspiratory-muscle endurance
in both groups was around 50% of Pimax value.
After 6 weeks of training, mean inspiratory-muscle
endurance (% Pimax) in the control group increased from
50% to 54% (P=0?197). In the training group, mean
inspiratory-muscle endurance (% Pimax) increased signifi-TABLE 2. Physiologic variables (mean SD values)
Control
Pre
(n=8)
Post
(n=8)
P-value
FEV1 (l) 2?46 (1?24) 2?56 (1?09) 0?565
FEV1 (% pred.) 70 (29) 73 (29) 0?604
FVC (l) 3?30 (1?08) 3?33 (0?95) 0?828
FVC (% pred.) 80 (20) 80 (21) 0?934
Wmax (W) 125 (48) 126 (48) 0?685
VO2 max (ml kg
71min71) 33 (10) 30 (11) 0?082
VEmax (l/min) 59 (25) 58 (20) 0?845
Pimax (% pred.) 129 (32) 139 (36) 0?103
IME (%Pimax) 50 (5) 54 (7) 0?197
IME: inspiratory muscle endurance; Pimax: maximal static ins
*significant difference between pre- and postvalue in the contro
samples;
**significant difference in change from baseline between the
unpaired samples.cantly from 49% to 66% (P=0?003). Analysis showed that
the change in inspiratory muscle endurance (% Pimax) in
the training group was significantly higher than in the
control group (P=0?012) (Figure 1). Concerning all other
physiologic variables, after 6 weeks of training no
significant within group differences and no significant
differences in changes from baseline between the groups
(Table 2) were found. According to Borg- and MRC-
dyspnoea scores, and subjective Fatigue scores after
training, no significant within group differences and no
significant differences in changes from baseline between the
groups (Table 3) were found.
Discussion
In the present study it was found that inspiratory-threshold
loading 20 min a day, 5 days a week during 6 weeks
significantly improved inspiratory-muscle endurance, but
not inspiratory-muscle strength, pulmonary function, ex-
ercise capacity, dyspnoea and fatigue in CF patients.
The finding that inspiratory muscle training leads to an
increased endurance capacity of the inspiratory muscles is
in agreement with the results of Asher et al. (9). However,
in contrast with the finding of the present study, Asher et al.
also found an improved inspiratory-muscle strength after
their training programme. Sawyer et al. (10) found
increased strength of the inspiratory muscles, but did not
report endurance capacity. It is unlikely that differences
between these outcomes and the result of the present study
can be explained by differences in initial Pimax values (%
predicted) before training. In the study by Sawyer and in
the present study Pimax was well preserved, with valuesTraining Change from baseline
between control and
training
Pre
(n7)
Post
(n=7)
P-value P-value
2?27 (0?77) 2?33 (0?71) 0?268 0?822
72 (27) 70 (21) 0?541 0?460
3?03 (1?02) 3?07 (0?90) 0?703 0?999
80 (22) 79 (18) 0?699 0?789
111 (48) 106 (44) 0?172 0?166
33 (8) 29 (6) 0?171 0?995
45 (17) 40 (15) 0?095 0?347
105 (23) 123 (21) 0?064 0?401
49 (12) 66 (14) 0?003* 0?012**
piratory pressure;
l group or training group analysed using the t-test for paired
training and the control group analysed using the t-test for
TABLE 3. Subjective variables (mean SD values)
Control Training Change from baseline
between control
and training
Pre
(n=8)
Post
(n=8)
P-value Pre
(n7)
Post
(n=7)
P-value P-value
Borgmax, endurance 1?0 (1?8) 1?0 (1?8) 0?305 1?4 (1?2) 1?3 (1?3) 0?220 0?603
Borgmax, bicycle 4?2 (3?3) 4?5 (3?3) 0?551 5?3 (2?7) 4?3 (3?5) 0?263 0?197
MFI-GF 6?63 (3?70) 8?00 (4?56) 0?390 7?57 (4?50) 6?43 (2?76) 0?364 0?208
MFI-PF 7?88 (5?30) 7?75 (4?68) 0?802 6?71 (3?90) 6?57 (4?24) 0?805 0?981
MFI-RA 6?88 (4?36) 8?25 (5?29) 0?181 5?14 (1?22) 6?57 (1?99) 0?065 0?960
MFI-RM 5?00 (1?41) 8?38 (5?18) 0?073 5?14 (1?46) 5?00 (1?53) 0?859 0?076
MFI-MF 6?38 (3?20) 9?75 (5?68) 0?185 6?57 (1?51) 7?29 (2?56) 0?376 0?301
MRC dyspnoea 0?63 (1?06) 0?50 (0?76) 0?351 0?43 (0?79) 0?33 (0?82) 0?541 0?351
Borgmax, endurance: Borg score at maximal work load during inspiratory-muscle endurance test;
Borgmax, bicycle: Borg score at maximal work load during bicycle ergometry test;
MFI-GF: Multidimensional Fatigue Inventory-General Fatigue score;
MFI-PF: Multidimensional Fatigue Inventory-Physical Fatigue score;
MFI-RA: Multidimensional Fatigue Inventory-Reduced Activity score;
MFI-RM: Multidimensional Fatigue Inventory-Reduced Motivation score;
MFI-MF: Multidimensional Fatigue Inventory-Mental Fatigue score;
MRC dyspnoea: Medical Research Council dyspnoea scale.
Differences between pre- and post-value within the control group and within the training group were analysed using the t-test
for paired samples.
Differences in change from baseline between the training and the control group were analysed using the t-test for unpaired
samples.
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differences between the studies in intensity and duration
of the inspiratory-muscle training programmes. Asher
trained patients twice daily with 15min each session on
maximal possible resistance. Sawyer applied inspiratory-
threshold loadings up to 60% Pimax for 10 weeks, 30min a
day. Intensity of the present training programme was much
lower, with loads up to 40% of Pimax in the training group.
It has been suggested that low-intensity training results in
improvement in inspiratory-muscle endurance and that
high-intensity training specifically improves inspiratory-
muscle strength (21,26). This may explain the fact that the
authors only found an effect on inspiratory-muscle
endurance and not on inspiratory-muscle strength.
In addition, it should be noted that in the present study
after training patients in the training group showed a
tendency of improvement in Pimax (from 105 to 123%
predicted), which just fell short of statistical significance
(P=0?064). The lack of significant improvement in Pimax
might be related to the relatively small number of patients
presented in our training group (n=7) as compared to the
studies of Asher et al. (n=11) and Sawyer et al. (n=10).
The improvement in Pimax might have been statistically
significant had more patients been tested. Endurancecapacity of the inspiratory muscles in the present group
of patients was lower than described in elderly persons and
non-elderly asymptomatic persons (19). It has been shown
that ‘normal’ endurance is around 80%, while the CF
patients in the present study had an endurance of only 50%
prior to the training. The improvement to 66% in the
training group was significant, but the endurance remained
lower than normal. The increased inspiratory-muscle
endurance in the present study did not result in transfer
effects like increased pulmonary function, exercise capacity,
reduced dyspnoea or less fatigue as was hypothesized
beforehand. This finding confirms the results of Asher et al.
(9), who found no effect of inspiratory-muscle training on
exercise capacity in CF patients. In contrast, Sawyer et al.
(10) found an increased exercise capacity measured as
endurance on a treadmill. Surprisingly, in this study
improvement in pulmonary function was found in the
inspiratory-muscle training group. The reason for the
improvement in pulmonary function in the study of Sawyer
is not clear and could not be confirmed by this study.
Redline et al. (27) found that in healthy subjects
inspiratory-muscle training resulted in increased muscle
strength but also reduced sensation of inspiratory effort.
This could not however be confirmed in the present study.
36 W. DE JONG ET AL.Moreover, it was found that functional status as measured
by the MRC scale and the MFI-20 questionnaire did not
improve due to inspiratory-muscle training.
In conclusion, low-intensity inspiratory-threshold load-
ing leads to an increased inspiratory-muscle endurance in
these particular CF patients. Further studies involving
larger numbers of patients are required in order to clarify
whether low-intensity inspiratory-muscle training could
elicit significant improvements in Pimax. Furthermore,
research is needed to determine the specific and transfer
effects of inspiratory-muscle training in patients with CF.
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